Gamida Cell Ltd. has named industry stalwart Dr. Joe Wiley as Chief Executive Officer. Dr. Joe Wiley founded Amryt Pharma and served as the CEO until it was acquired by Chiesi Farmaceutici in April 2023. Prior to his role at Amryt, Wiley served as the Principal at Sofinnova Ventures and Medical Director at Astellas Pharma, and he held multiple investment management roles following his work as a neurologist.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.017 USD | +2.41% | -.--% | -95.88% |
Jun. 18 | Gamida Cell Names Rory Nealon as Chief Financial Officer | CI |
Jun. 18 | Gamida Cell Names Sheila Frame as Chief Commercial Officer | CI |
1st Jan change | Capi. | |
---|---|---|
-95.88% | 2.62M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- GMDA Stock
- News Gamida Cell Ltd.
- Gamida Cell Ltd. Names Joe Wiley as Chief Executive Officer